Detalhe da pesquisa
1.
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Lancet
; 401(10378): 747-761, 2023 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36746171
2.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Br J Dermatol
; 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38576350
3.
Inflammatory and vaso-occlusive ulcers: Part I - clinical presentation and diagnosis.
J Am Acad Dermatol
; 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38432459
4.
Inflammatory and vaso-occlusive ulcers: Part II - Management.
J Am Acad Dermatol
; 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38432460
5.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
J Am Acad Dermatol
; 90(3): 521-529, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37871805
6.
The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis.
Dermatology
; 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38354718
7.
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.
J Eur Acad Dermatol Venereol
; 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38595320
8.
Lower Extremity Angiosarcoma: A Life-Threatening Complication of Lymphedema.
Adv Skin Wound Care
; 37(5): 268-270, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38648240
9.
Wound Bed Preparation 2024: Delphi Consensus on Foot Ulcer Management in Resource-Limited Settings.
Adv Skin Wound Care
; 37(4): 180-196, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38354304
10.
Anemia and Systemic Inflammatory Markers in Patients with Perianal Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease.
Dermatology
; 239(5): 843-848, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37356426
11.
Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
Dermatology
; 239(5): 732-737, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37385230
12.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
Dermatology
; 239(3): 362-367, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36630943
13.
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study.
J Eur Acad Dermatol Venereol
; 37(10): 2098-2108, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37317022
14.
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.
J Eur Acad Dermatol Venereol
; 37(2): 395-401, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36184889
15.
Cutaneous Adverse Reactions Following Influenza Vaccination in Adults.
Adv Skin Wound Care
; 36(6): 317-321, 2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37212565
16.
Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.
Br J Dermatol
; 186(5): 803-813, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34978076
17.
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Br J Dermatol
; 187(6): 927-935, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36056741
18.
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
J Am Acad Dermatol
; 86(5): 1092-1101, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33493574
19.
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.
Dermatology
; 238(3): 430-437, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34537770
20.
The Incidence and Risk of Respiratory Tract Infections in Patients Using Biologics for Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.
J Drugs Dermatol
; 21(8): 819-824, 2022 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35946977